Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912404136> ?p ?o ?g. }
- W2912404136 endingPage "535" @default.
- W2912404136 startingPage "528" @default.
- W2912404136 abstract "Despite the availability of a large number of therapeutic options throughout the world, rates of optimal glycaemic control in adult patients with type 2 diabetes mellitus remain low. Delays in treatment intensification to insulin and low adherence to insulin regimes, which are well-documented contributors to poor glycaemic control, are in many cases driven by fear of hypoglycaemic events, weight gain and injections. Over the last 10 years, injectable glucagon-like peptide-1 receptor agonists (GLP1-RAs) have emerged as alternatives to basal insulin for treatment intensification in patients inadequately controlled with oral antidiabetic drugs. As a class, GLP1-RAs are associated with weight loss and fewer hypoglycaemic events than insulin. In addition, some of them are available in once-a-week formulations and therefore require fewer injections. However, as randomized controlled trials are not representative of everyday practice, physicians should consider the results of real-life studies to guide their treatment decisions. In this review, while significant variations in efficacy, tolerability and adherence data were noted from one study to another, rates of glycaemic control overall were low. Indeed, our present analysis has suggested that regular re-evaluations of treatment, including response, tolerability, adherence, cost and quality of life, are necessary." @default.
- W2912404136 created "2019-02-21" @default.
- W2912404136 creator A5000309355 @default.
- W2912404136 creator A5003323204 @default.
- W2912404136 creator A5025169113 @default.
- W2912404136 creator A5039339457 @default.
- W2912404136 creator A5041840200 @default.
- W2912404136 creator A5047653403 @default.
- W2912404136 creator A5064287355 @default.
- W2912404136 date "2019-12-01" @default.
- W2912404136 modified "2023-10-18" @default.
- W2912404136 title "Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings" @default.
- W2912404136 cites W1976812315 @default.
- W2912404136 cites W1978047113 @default.
- W2912404136 cites W1979422476 @default.
- W2912404136 cites W2032451413 @default.
- W2912404136 cites W2036387352 @default.
- W2912404136 cites W2043900831 @default.
- W2912404136 cites W2047187313 @default.
- W2912404136 cites W2048978130 @default.
- W2912404136 cites W2054568668 @default.
- W2912404136 cites W2055754603 @default.
- W2912404136 cites W2059909265 @default.
- W2912404136 cites W2062098402 @default.
- W2912404136 cites W2065829166 @default.
- W2912404136 cites W2085539413 @default.
- W2912404136 cites W2096416969 @default.
- W2912404136 cites W2120779228 @default.
- W2912404136 cites W2124234371 @default.
- W2912404136 cites W2137352234 @default.
- W2912404136 cites W2137665561 @default.
- W2912404136 cites W2139485303 @default.
- W2912404136 cites W2160088494 @default.
- W2912404136 cites W2194838818 @default.
- W2912404136 cites W2199038420 @default.
- W2912404136 cites W2208246363 @default.
- W2912404136 cites W2400230962 @default.
- W2912404136 cites W2425644022 @default.
- W2912404136 cites W2430926173 @default.
- W2912404136 cites W2462710388 @default.
- W2912404136 cites W2471756691 @default.
- W2912404136 cites W2495635954 @default.
- W2912404136 cites W2519510391 @default.
- W2912404136 cites W2533109792 @default.
- W2912404136 cites W2552473439 @default.
- W2912404136 cites W2578084918 @default.
- W2912404136 cites W2585146202 @default.
- W2912404136 cites W2586129535 @default.
- W2912404136 cites W2594000342 @default.
- W2912404136 cites W2595744872 @default.
- W2912404136 cites W2597203198 @default.
- W2912404136 cites W2617078900 @default.
- W2912404136 cites W2620356640 @default.
- W2912404136 cites W2624755170 @default.
- W2912404136 cites W2738595939 @default.
- W2912404136 cites W2743088090 @default.
- W2912404136 cites W2745199969 @default.
- W2912404136 cites W2750917994 @default.
- W2912404136 cites W2751938332 @default.
- W2912404136 cites W2763255780 @default.
- W2912404136 cites W2766836053 @default.
- W2912404136 cites W2770973170 @default.
- W2912404136 cites W2778234808 @default.
- W2912404136 cites W2828406404 @default.
- W2912404136 cites W2894746763 @default.
- W2912404136 cites W906438903 @default.
- W2912404136 doi "https://doi.org/10.1016/j.diabet.2019.01.006" @default.
- W2912404136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30677504" @default.
- W2912404136 hasPublicationYear "2019" @default.
- W2912404136 type Work @default.
- W2912404136 sameAs 2912404136 @default.
- W2912404136 citedByCount "22" @default.
- W2912404136 countsByYear W29124041362019 @default.
- W2912404136 countsByYear W29124041362020 @default.
- W2912404136 countsByYear W29124041362021 @default.
- W2912404136 countsByYear W29124041362022 @default.
- W2912404136 countsByYear W29124041362023 @default.
- W2912404136 crossrefType "journal-article" @default.
- W2912404136 hasAuthorship W2912404136A5000309355 @default.
- W2912404136 hasAuthorship W2912404136A5003323204 @default.
- W2912404136 hasAuthorship W2912404136A5025169113 @default.
- W2912404136 hasAuthorship W2912404136A5039339457 @default.
- W2912404136 hasAuthorship W2912404136A5041840200 @default.
- W2912404136 hasAuthorship W2912404136A5047653403 @default.
- W2912404136 hasAuthorship W2912404136A5064287355 @default.
- W2912404136 hasBestOaLocation W29124041361 @default.
- W2912404136 hasConcept C126322002 @default.
- W2912404136 hasConcept C134018914 @default.
- W2912404136 hasConcept C159110408 @default.
- W2912404136 hasConcept C168563851 @default.
- W2912404136 hasConcept C170493617 @default.
- W2912404136 hasConcept C185280430 @default.
- W2912404136 hasConcept C197934379 @default.
- W2912404136 hasConcept C2776398474 @default.
- W2912404136 hasConcept C2777180221 @default.
- W2912404136 hasConcept C2778375690 @default.
- W2912404136 hasConcept C2778938600 @default.
- W2912404136 hasConcept C2779306644 @default.